SpyGlass Pharma, Inc. (SGP)

NASDAQ

$26.38

$+1.63

(+6.61%)

Pre-Market

SpyGlass Pharma, Inc. (SGP) Live Price Chart

Last updated: ⁦2026-10-21 12:58:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

SpyGlass Pharma, Inc. (SGP) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $26.38, with a market capitalization of $822.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.06 to $32.44. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$822.82M
Open	$24.49
Day's High	$35.15
Day's Low	$11.97
Previous Close	$24.60
Volume	91.72K
Average Volume	99.72K
P/E Ratio	--
52-Week High	$32.44
52-Week Low	$17.06
Dividend Yield	--
Earnings Date	--

SpyGlass Pharma, Inc. (SGP) Pre-Market Stock Price

SpyGlass Pharma, Inc. (SGP) is trading at $25.02 in pre-market trading as of 2026-10-20 23:31:00, up 1.69% ($0.41) from the previous close of $24.60

Pre-market trading shows how investors are pricing SGP before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

SpyGlass Pharma, Inc. (SGP) 7-Day Stock Price Change

Over the past seven days, SpyGlass Pharma, Inc. (SGP) moved from $24.86 to $26.38, representing a gain of 6.11% ($1.52).

The stock traded between $22.80 and $26.70 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 65.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

SGP 52-Week Price Position

Position in Range: 60.6%

52W Low$17.06

52W High$32.44

SGP is currently trading at $26.38, placing it 60.6% of the way from its 52-week low of $17.06 to its 52-week high of $32.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is SpyGlass Pharma, Inc. (SGP)?

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

SpyGlass Pharma, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	65
Exchange	NASDAQ
Company Website	https://www.spyglasspharma.com

How to Buy SpyGlass Pharma, Inc. (SGP) Stock on MEXC

Eligible investors can buy real shares of SpyGlass Pharma, Inc. (SGP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SGP and Place Your Order

Open the RealStocks trading page and search for SGP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is SpyGlass Pharma, Inc. (SGP) stock price today?

SpyGlass Pharma, Inc. (SGP) is currently trading at $ 26.38, up 7.24% ($1.78) from the previous close of $ 24.60. Intraday prices update in real time during regular trading hours.

2.Is SGP stock going up or down today?

As of 2026-10-20 23:31:00, SGP is trading at $ 26.38, up 7.24% ($1.78) from its previous close of $ 24.60. The stock has traded between $ 11.97 and $ 35.15 during today’s regular session. Past price movements do not guarantee future results.

3.What is SGP pre-market price?

As of 2026-10-20 23:31:00, SGP is trading at $ 25.02 in pre-market trading, up 1.69% ($0.41) from the previous close of $ 24.60. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SGP after-hours price?

As of 2026-10-20 23:31:00, SGP is trading at $ 26.38 in after-hours trading, up 7.24% ($1.78) from the regular-session close of $ 24.60. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SGP stock trading now?

SGP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SGP sit relative to its 52-week high and low?

Over the past 52 weeks, SGP has traded between a low of $ 17.06 and a high of $ 32.44. At $ 26.38, the stock is positioned 60.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is SpyGlass Pharma, Inc. in?

SpyGlass Pharma, Inc. (SGP) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is SpyGlass Pharma, Inc.'s market capitalization and where is it listed?

SpyGlass Pharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 822.82M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SGP valued in terms of P/E ratio and EPS?

SGP trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does SpyGlass Pharma, Inc. pay a dividend?

SpyGlass Pharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.